Emergent BioSolutions (EBS) Assets Average (2011 - 2026)

Emergent BioSolutions' Assets Average history runs 16 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Assets Average fell 6.28% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 6.28% YoY), while the FY2025 annual figure was $1.4 billion, down 15.71% from the prior year.
• Assets Average was $1.3 billion for Q1 2026 at Emergent BioSolutions, down from $1.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $3.1 billion in Q1 2023 to a low of $1.3 billion in Q1 2026.
• Historically, Assets Average has averaged $2.0 billion across 5 years, with a median of $1.8 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average climbed 6.59% in 2023, then plunged 40.7% in 2024.
• A 5-year view of Assets Average shows it stood at $3.0 billion in 2022, then slumped by 38.7% to $1.9 billion in 2023, then dropped by 22.84% to $1.4 billion in 2024, then decreased by 3.07% to $1.4 billion in 2025, then decreased by 5.06% to $1.3 billion in 2026.
• The last three Assets Average figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.